(NASDAQ: AMED) Amedisys's forecast annual revenue growth rate of 4.64% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Amedisys's revenue in 2024 is $2,251,407,000.On average, 8 Wall Street analysts forecast AMED's revenue for 2024 to be $75,885,646,809, with the lowest AMED revenue forecast at $75,163,357,076, and the highest AMED revenue forecast at $77,147,693,230. On average, 6 Wall Street analysts forecast AMED's revenue for 2025 to be $80,371,300,020, with the lowest AMED revenue forecast at $78,143,488,441, and the highest AMED revenue forecast at $83,362,704,908.
In 2026, AMED is forecast to generate $85,825,822,694 in revenue, with the lowest revenue forecast at $85,825,822,694 and the highest revenue forecast at $85,825,822,694.